. . . . . . . . . "votrient r votrient is indicated for the treatment of patients with advanced soft tissue sarcoma sts who have received prior chemotherapy limitation s of use votrient is a kinase inhibitor indicated for the treatment of patients with advanced renal cell carcinoma 1 advanced soft tissue sarcoma who have received prior chemotherapy 1 limitation s of use" . . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "N0mp/1ASlHf6sKsxamj20OzxZfUM6X80sUMWlHMHkjBmFqwOYPEUbrkskCGwQ5MRr/Y2fgEKOUu9PdGH4ftvFfr+cTAon0eEGOka/tPWowLvNGpVZlsjMi/UwiVf0GJXYELaioA9O8ulQqIoFjzLlIVsvvcgtYzaVpRsoXOU/EM=" . . "2021-06-21T09:59:00.710+02:00"^^ . . . . .